Private company
Northpond Ventures, LP
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Northpond Ventures, LP sits at the top of its group. 8 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Northpond Ventures, LP DE
- Bruker Cellular Analysis, Inc. Stake · Emeryville, California
- Candel Therapeutics Stake · Auburndale
- DICE Therapeutics, Inc. Stake · South San Francisco, California
- IsoPlexis Corp Stake · Branford, Connecticut
- Mereo BioPharma Group plc Stake · London, United Kingdom
- Telesis Bio Inc. Stake · San Diego, California, United States
- Vigil Neuroscience, Inc. Stake · Watertown, Massachusetts
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.
Stakes it holds
Northpond Ventures, LP has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).
- Mereo BioPharma Group plcSCHEDULE 13G/A Jun 11, 2025 to Feb 17, 20262
- Vigil Neuroscience, Inc.SCHEDULE 13D/A Jan 19, 2022 to May 27, 20253
- Candel TherapeuticsSCHEDULE 13G/A Feb 14, 2022 to Feb 14, 20254
- Telesis Bio Inc.SC 13D/A Apr 19, 2023 to Nov 6, 20245
- DICE Therapeutics, Inc.SC 13D/A Nov 10, 2022 to Jun 23, 20236
- IsoPlexis CorpSC 13D/A Oct 22, 2021 to Jun 15, 20237
- Bruker Cellular Analysis, Inc.SC 13G Mar 29, 20238
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8